Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 26 to 50 of 1959 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
2443 Increase, Hepatocyte injury
0 Tissue Jul 9, 2026 Jul 9, 2026 None
2442 Increase, Abnormal lipid accumulation
0 Organ Jul 9, 2026 Jul 9, 2026 None
2441 Increased , Fatty acid synthesis and transport
0 Tissue Jul 9, 2026 Jul 9, 2026 646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
2440 Increase, Hepatic inflammation
0 Tissue Jul 9, 2026 Jul 9, 2026 None
2439 Increase, Telomere attrition
0 Molecular Jul 9, 2026 Jul 9, 2026 645: Binding and activation of AhR lead to cardiovascular aging
2438 Increase, Cardiovascular aging
0 Individual Jul 9, 2026 Jul 9, 2026 645: Binding and activation of AhR lead to cardiovascular aging
2437 Increase, Blood pressure elevation
0 Tissue Jul 9, 2026 Jul 9, 2026 None
2436 Increase, Systemic inflammation
0 Cellular Jul 9, 2026 Jul 9, 2026 None
2435 Increase, Myocardial and vascular structural remodeling
0 Tissue Jul 9, 2026 Jul 9, 2026 645: Binding and activation of AhR lead to cardiovascular aging
2434 Disruption, Mitochondrial dysfunction
0 Cellular Jul 9, 2026 Jul 9, 2026 None
2433 Decrease, Telomere attrition
0 Molecular Jul 9, 2026 Jul 9, 2026 None
2432 Increase, Cell cycle arrest
0 Cellular Jul 9, 2026 Jul 9, 2026 645: Binding and activation of AhR lead to cardiovascular aging
2431 Impact on sirtuins-related aging signaling pathway gene expression
0 Molecular Jul 9, 2026 Jul 9, 2026 645: Binding and activation of AhR lead to cardiovascular aging
2430 Aryl hydrocarbon receptor(AhR)activation
0 Molecular Jul 9, 2026 Jul 9, 2026
2429 Instability/dysfunction of INSIG1
0 Molecular Jun 9, 2026 Jun 9, 2026 None
2428 Gut derived PAMPs, increased
0 Cellular Apr 23, 2026 Apr 23, 2026 642: Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation
2427 Bile acid composition in bile and intestine, altered
0 Cellular Apr 23, 2026 Apr 23, 2026 642: Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation
2426 Hepatic BSEP (ABCB11), decreased
0 Cellular Apr 23, 2026 Apr 23, 2026 642: Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation
2425 Intrahepatic bile acid burden, increased
0 Cellular Apr 23, 2026 Apr 23, 2026 642: Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation
2424 Hepatic CYP7A1, increased
0 Cellular Apr 22, 2026 Apr 22, 2026 642: Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation
2423 Hepatic SHP, decreased
0 Cellular Apr 22, 2026 Apr 22, 2026 232: NFE2/Nrf2 repression to steatosis
2422 Ileal FGF15/FGF19 secretion, decreased
0 Cellular Apr 22, 2026 Apr 22, 2026 642: Intestinal FXR inhibition leading to steatohepatitis via gut‑liver axis dysregulation
2421 Inhibition, Intestinal FXR
0 Molecular Apr 22, 2026 Apr 22, 2026
2420 Increased, Retinoic Acid Receptor Activation
0 Tissue Apr 22, 2026 Apr 23, 2026 400: Inhibition of CYP26B1 activity in fetal testis leading to reduced fertility
2419 Decreased, Retinoic Acid Receptor Activation
0 Tissue Apr 22, 2026 Apr 23, 2026